For Instant Control of Nausea Associated with Acidity

No Acidity. No Nausea.

Erazole 40 Summary Table

Parameter	Details
Brand name	EraZole-40
Composition	Esomeprazole 40 mg
Dosage form	Tablet
Therapeutic class	Proton pump inhibitor (PPI)
Mechanism of action	Inhibits H⁺/K⁺-ATPase enzyme to suppress gastric acid secretion
Indications	GERD, hyperacidity, peptic ulcer, duodenal ulcer, dyspepsia, reflux esophagitis
Recommended dose	1 tablet daily before meals
Common side effects	Headache, nausea, abdominal discomfort, diarrhea
Precautions	Monitor long-term use; caution in liver disease
Storage	Store below 30°C, dry and protected from light
Key advantages	Strong acid suppression, rapid relief, once-daily dosing

Product Summary

EraZole-40 contains Esomeprazole 40 mg, a next-generation proton pump inhibitor (PPI) that provides powerful and sustained acid suppression. It is designed for the effective management of acid-related gastrointestinal disorders, offering rapid relief from hyperacidity, heartburn, and nausea associated with acid reflux.

By inhibiting gastric acid secretion at its source, EraZole-40 helps restore digestive comfort and promotes healing of the gastric and esophageal mucosa.

Key Benefits

➤ Complete Acid Suppression

Potently inhibits gastric acid secretion
Provides long-lasting relief from acidity and heartburn
Helps maintain optimal gastric pH

➤ Relief from Nausea Associated with Acidity

Reduces acid irritation in the stomach
Helps control nausea and discomfort linked to reflux

➤ Promotes Healing of GI Mucosa

Supports healing of erosive esophagitis
Effective in peptic and duodenal ulcers

➤ Once-Daily Convenience

Sustained action with a single daily dose
Improves compliance and patient outcomes

Mechanism of Action

Esomeprazole (40 mg)

Proton pump inhibitor (PPI)
Blocks the H⁺/K⁺-ATPase enzyme in gastric parietal cells
Suppresses both basal and stimulated acid secretion
Promotes healing of acid-related damage in the stomach and esophagus

Indications

EraZole-40 is indicated for:

Hyperacidity
Gastroesophageal reflux disease (GERD)
Reflux esophagitis
Peptic ulcer disease
Duodenal ulcer
Dyspepsia
Acid-related nausea

Dosage & Administration

One tablet daily, preferably before meals
Swallow whole; do not crush or chew
Use as directed by physician

Side Effects

Generally well tolerated:

Headache
Nausea
Abdominal pain
Diarrhea or constipation
Flatulence

Precautions

Long-term use may require monitoring of Vitamin B12 and magnesium levels
Use cautiously in liver impairment
Avoid unnecessary prolonged use without medical supervision
Not recommended in pregnancy unless prescribed

Storage

Store below 30°C, in a cool and dry place.
Protect from moisture and sunlight.

Key Advantages of EraZole-40

Advanced PPI therapy for strong acid control
Provides rapid relief from acidity and nausea
Supports healing of ulcers and esophageal damage
Once-daily dosing for convenience
Clinically established efficacy and safety

References (APA 7)

Kahrilas, P. J., Shaheen, N. J., Vaezi, M. F., & American Gastroenterological Association. (2008). American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology, 135(4), 1383–1391. https://doi.org/10.1053/j.gastro.2008.08.045

Sharma, P., & Vakil, N. (2011). Review article: Acid suppression and proton pump inhibitors in gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics, 34(2), 123–136. https://doi.org/10.1111/j.1365-2036.2011.04707.x

Strand, D. S., Kim, D., & Peura, D. A. (2017). 25 Years of proton pump inhibitors: A comprehensive review. Gut and Liver, 11(1), 27–37. https://doi.org/10.5009/gnl15502

Moayyedi, P., & Delaney, B. (2010). Gastro-oesophageal reflux disease. The Lancet, 375(9713), 119–128. https://doi.org/10.1016/S0140-6736(09)60691-0

Forgacs, I., & Loganayagam, A. (2008). Overprescribing proton pump inhibitors. BMJ, 336(7634), 2–3. https://doi.org/10.1136/bmj.39406.449456.BE